Aclarubicin

(1R,2R,4S)-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester; [1R-(1α,2β,4β)]-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester; Aclacinomycin A; Aclacur; Antibiotic 3082A; Antibiotic 77-3082A; Antibiotic MA 144A1; Jaclacin; NSC 208734;

OC1=C2C(C(C(C=C([C@@H](C(OC)=O)[C@@](O)(CC)C[C@@H]3O[C@@]4([H])C[C@H](N(C)C)[C@H](O[C@]5([H])O[C@@H](C)[C@@H](O[C@@]6([H])CCC([C@H](C)O6)=O)[C@@H](O)C5)[C@H](C)O4)C3=C7O)=C7C2=O)=O)=CC=C1